Wall Street Zen Upgrades Protagenic Therapeutics (NASDAQ:PTIX) to “Sell”
Protagenic Therapeutics (NASDAQ:PTIX – Get Free Report) was upgraded by stock analysts at Wall Street Zen to a “sell” rating in a note issued to investors on Saturday. Protagenic Therapeutics Stock Performance Shares of PTIX opened at $4.76 on Friday. The stock has a 50-day simple moving average of $3.85 and a 200-day simple moving […]
Protagenic Therapeutics (NASDAQ:PTIX – Get Free Report) was upgraded by stock analysts at Wall Street Zen to a “sell” rating in a note issued to investors on Saturday. Protagenic Therapeutics Stock Performance Shares of PTIX opened at $4.76 on Friday. The stock has a 50-day simple moving average of $3.85 and a 200-day simple moving […]
